PM Narendra Modi, on Wednesday, announced that India’s pharmaceutical products initiative ‘Jan Aushadhi Kendra’ will be set ...

India is showing real commitment to realize its vision of becoming a “pharmacy of the world” by implementing policies and ...

There are some very clear opportunities for companies but more deliberate action is needed, says Claudia Martinez, Director of Research at the Access to Medicine Foundation.

India’s pharmaceutical sector has seen remarkable growth in the past few years and is expected to reach a market value of USD ...

India's Finance Minister emphasizes the need for unique pharmaceutical standards and branding India as a hub for innovative solutions.

Dr Murali Krishna Prasad Divi became a billionaire in 2013 with a net worth of $1.16 billion (Rs 9789 crore) according to ...

The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month ...

NEW DELHI: The Trump 2.0 agenda, with its likely focus on China plus 1 strategy for pharmaceutical manufacturing and supply chain diversification, provides an incremental opportunity for Indian ...

Barriers are arising in the supply chains of food, fuel, fertiliser, and pharmaceuticals. Those whom we considered ...

Zepto has secured $350 million in new funding, its third round of financing in six months, as the Indian quick-commerce ...

SAO PAULO (Reuters) - Brazil President Luiz Inacio Lula da Silva said on Tuesday he spoke with India's Prime Minister ...

What is the category of Nippon India Pharma Fund - Direct Plan - Growth Plan ? The category of Nippon India Pharma Fund - Direct Plan - Growth Plan is Equity - Sector - Healthcare What is the ...